Bill
A 265
Relates to the availability of opioid reversal agents
2025 Regular Session
Introduced by Scott Bendett and 15 co-sponsors
Bill A 265 increases access to opioid reversal agents like naloxone without prescriptions, ensuring training and awareness to combat opioid overdoses and save lives.
DELIVERED TO SENATE